Search results for "CYP"

showing 10 items of 480 documents

Screening of antiinflammatory medicinal plants used in traditional medicine against skin diseases

1998

The antiinflammatory activity of twelve medicinal plants used against skin disorders were tested in different experimental models of topical inflammation and one in vitro inhibitory test against phospholipase A2 (PLA2) from Naja naja venom. Forsythia suspensa was the most active species on the arachidonic acid (AA) topical test. This last species together with Astragalus membranaceus and Ranunculus sceleratus were the most active on the 12-O-tetradecanoylphorbol-13-acetate (TPA) acute ear oedema test. Scrophularia auriculata was the most active on multiple topical applications of TPA and on the oxazolone-induced delayed type hypersensitivity (DTH). Santolina chamaecyparissus was the only sp…

PharmacologyForsythia suspensaintegumentary systemTraditional medicinebiologybusiness.industryScrophularia auriculatabiology.organism_classificationlaw.inventionSantolina chamaecyparissusAstragaluschemistry.chemical_compoundPhospholipase A2chemistrylawbiology.proteinMedicineArachidonic acidPhytotherapyMedicinal plantsbusinessPhytotherapy Research
researchProduct

Genetics of the variable expression of CYP3A in humans.

2004

CYP3A isozymes participate in the metabolism of 45-60% of currently used drugs and of a variety of other compounds such as steroid hormones, toxins, and carcinogens. The CYP3A expression status is a major determinant of drug efficacy and safety, and it may also affect an individual's predisposition to certain cancers. The inter- and intraindividual expression of CYP3A is variable because of a complex interplay between genetic and environmental factors. Markers predictive of the individual CYP3A activity could improve therapies with CYP3A substrates by personalised dose adjustments, but their development has been slower than for other drug-metabolizing enzymes. Here we summarize the recent p…

PharmacologyGeneticsRegulation of gene expressionPolymorphism GeneticCYP3A4GenomicsOxidoreductases N-DemethylatingBiologyIsozymeGene Expression Regulation EnzymologicVariable ExpressionPharmaceutical PreparationsOrgan SpecificityCytochrome P-450 CYP3ACytochrome P-450 CYP3AHumansPharmacology (medical)PharmacokineticsAryl Hydrocarbon HydroxylasesCYP3A5HormoneTherapeutic drug monitoring
researchProduct

Die Wirkung von Cyproheptadin auf die Winterschlafbereitschaft und die jahreszeitlichen Körpergewichtsänderungen beim sibirischen BackenhörnchenTamia…

1971

The effect of cyproheptadin (4 mg/kg per os) on the typical weight cycle of sibirian chipmunksTamias (Eutamias)sibiricus before and during the hibernation period was studied. The substance leads to a complete inhibition of hibernation and the bodyweight reaches a lower level than in control animals.

PharmacologyHibernationCellular and Molecular NeuroscienceAnimal sciencebiologyPeriod (gene)Molecular MedicineCell BiologyCyproheptadinbiology.organism_classificationMolecular BiologyEutamiasExperientia
researchProduct

CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy

2020

Aim: The influence of variants in pharmacokinetics-related genes on long-term exposure to tacrolimus (TAC)-based therapy and clinical outcomes was investigated. Patients & methods: Brazilian kidney recipients were treated with TAC combined with everolimus (n = 178) or mycophenolate sodium (n = 97). The variants in CYP2C8, CYP2J2, CYP3A4, CYP3A5, POR, ABCB1, ABCC2, ABCG2, SLCO1B1 and SLCO2B1 were analyzed. Main results: CYP3A5*3/*3 genotype influenced increase in TAC concentration from week 1 to month 6 post-transplantation (p < 0.05). The living donor and CYP2C8*3 variant were associated with reduced risk for delayed graft function (OR = 0.07; 95% CI = 0.03–0.18 and OR = 0.45; 95% C…

PharmacologyKidneymedicine.medical_specialtyEverolimusbiologybusiness.industryGastroenterologyTacrolimusMycophenolic acidmedicine.anatomical_structurePharmacokineticsInternal medicineGeneticsmedicinebiology.proteinFARMACOCINÉTICAMolecular MedicineSLCO1B1CYP3A5businessCYP2C8medicine.drug
researchProduct

Quinol sulphate, a new conjugate of phenol in goldfish.

1983

1. Metabolism of phenol in goldfish yielded the known phenyl conjugates in fish--phenyl sulphate and phenyl glucuronide. Additionally, quinol sulphate, a new conjugate of phenol in fish, was detected.

PharmacologyPhenolChemistryHealth Toxicology and MutagenesisCyprinidaemacromolecular substancesGeneral MedicineMetabolismToxicologyBiochemistryHydroquinoneschemistry.chemical_compoundPhenolsGoldfishOrganic chemistryFish <Actinopterygii>PhenolAnimalssense organsChromatography Thin LayerGlucuronideChromatography High Pressure LiquidConjugateXenobiotica; the fate of foreign compounds in biological systems
researchProduct

Transcriptional regulation and expression of CYP3A4 in hepatocytes.

2007

CYP3A4 is the most abundantly expressed drug-metabolizing P450 enzyme in human liver and contributes to the metabolism of a large number of drugs in use today. CYP3A4 is constitutively expressed in adult hepatocytes but it can also be transcriptionally induced by a variety of structurally diverse xenochemicals. CYP3A4 strongly contributes to the important variability in the therapeutic and toxic effects of drugs owing to the major role it plays in xenobiotic metabolism and the large intra- and inter-individual variability to which it is subjected. The functional examination of up to 13 kb of the CYP3A4 5'-flanking region has revealed that the regulation of this gene is a complex issue, with…

PharmacologyRegulation of gene expressionPregnane X receptorTranscription GeneticClinical BiochemistryDown-RegulationBiologyPharmacologyRegulatory Sequences Nucleic AcidGene Expression Regulation EnzymologicCell biologyDrug developmentNuclear receptorCytochrome P-450 Enzyme SystemLiverRegulatory sequenceTranscriptional regulationHepatocytesAnimalsCytochrome P-450 CYP3AHumansTranscription factorDrug metabolismCurrent drug metabolism
researchProduct

Pharmacological Study of Santolina chamaecyparissus. I. Acute Toxicity, Antiinflammatory and Antiulcer Activity

1986

PharmacologySantolina chamaecyparissusComplementary and alternative medicineTraditional medicineOrganic ChemistryDrug DiscoveryPharmaceutical ScienceMolecular MedicineBiologybiology.organism_classificationAcute toxicityAnalytical ChemistryPlanta Medica
researchProduct

Isolation and identification of an antiinflammatory principle from santolina chamaecyparissus

1989

The chloroform extract from Santolina chamaecyparissus squarrosa exhibited a potent anti-inflammatory effect on carrageenan-induced oedema in the rat hind paw. β-Sytosteryl 3-β-D-glucoside, isolated by fractionating this extract, was anti-inflammatory in the above test, with intraperitoneal and oral ED50 values of 70 and 146 mg/kg, respectively.

PharmacologySantolina chamaecyparissusbiologyTraditional medicineChemistrybiology.organism_classificationED50Phytotherapy Research
researchProduct

Regio- and stereoselectivity in the metabolism of benzo[c]phenanthrene mediated by genetically engineered V79 Chinese hamster cells expressing rat an…

1998

Regio- and stereoselective metabolism mediated by cytochrome P450 (CYP) and metabolite-dependent cytotoxicity of benzo[c]phenanthrene (B[c]Ph) and its trans-3,4-dihydrodiol, the metabolic precursor of the carcinogenic fjord-region B[c]Ph-3,4-dihydrodiol 1,2-epoxides (B[c]PhDE), were investigated with V79 Chinese hamster cells genetically engineered for three rat and six human CYP isoforms. The order of the capabilities of the CYP isoforms to metabolize B[c]Ph was as follows: h1A1>r1A1>r1A2>h1B1>h1A2>r2B1>>h2E1>h2A6>h3A4. Regardless of the species, all individual CYP isoforms preferentially catalyzed the oxidation of B[c]Ph at the 5,6-position (K-region) except human CYP1A1 and human CYP1A2,…

PharmacologybiologyChemistryStereochemistryHealth Toxicology and MutagenesisBenzo(c)phenanthreneCYP1A2Cytochrome P450General MedicineMetabolismrespiratory systemToxicologybiology.organism_classificationChinese hamsterchemistry.chemical_compoundCell culturepolycyclic compoundsbiology.proteinStereoselectivityCarcinogenEnvironmental toxicology and pharmacology
researchProduct

Effects of Natural Products on Contact Dermatitis

2005

Some medicinal plants, which are known to produce allergic reactions, are also specifically used as anti- inflammatory agents. Among the more relevant plants, we report species with cinnamaldehyde, cinnamic alcohol, geraniol, hydroxycitronellal, eugenol and isoeugenol are all potential allergens. In addition, fragrances, which are mixtures of small-molecul ar-weight compounds, may induce allergic contact dermatitis due to fragrance-spe cific CD4 + and CD8 + T lymphocytes. Plants from the Asteraceae family used in folk medicine as anti-inflamma tories can cause allergic contact dermatitis because of its content in sesquiterpene lactones, which have been reported as the anti- inflammatory pri…

PharmacologybiologyHydroxycitronellalTraditional medicineChemistryImmunologyArbutinbiology.organism_classificationmedicine.diseaseHelichrysum italicumTerpeneSantolina chamaecyparissusIsoeugenolchemistry.chemical_compoundmedicineImmunology and AllergyOrganic chemistryAllergic contact dermatitisContact dermatitisCurrent Medicinal Chemistry - Anti-Inflammatory &amp; Anti-Allergy Agents
researchProduct